Sfoglia per Autore
The ion channels and transporters gene expression profile indicates a shift in excitability and metabolisms during malignant progression of Follicular Lymphoma
2019 Magi A.; Masselli M.; Sala C.; Guerriero A.; Laise P.; Puccini B.; Rigacci L.; Breschi C.; Crociani O.; Pillozzi S.; Arcangeli A.; Serena Pillozzi
hERG1 and CA IX expression are associated with disease recurrence in surgically resected clear cell renal carcinoma
2019 Lastraioli E.; Pillozzi S.; Mari A.; Tellini R.; Duranti C.; Baldazzi V.; Venturini S.; Minervini A.; Lapini A.; Nesi G.; Carini M.; Arcangeli A.
Peptides and small molecules blocking the CXCR4/CXCL12 axis overcome bone marrow-induced chemoresistance in acute leukemias
2019 Pillozzi S.; Bernini A.; Spiga O.; Lelli B.; Petroni G.; Bracci L.; Niccolai N.; Arcangeli A.
Structural and solution chemistry, antiproliferative effects, and serum albumin binding of three pseudohalide derivatives of auranofin
2019 Damiano Cirri, Maria Giulia Fabbrini, Lara Massai, Serena Pillozzi, Annalisa Guerri, Alessio Menconi, Luigi Messori, Tiziano Marzo, Alessandro Pratesi
hERG1 potassium channel expression predicts survival in clear-cell renal cell carcinoma: A pilot study with a long-term follow up
2019 Lastraioli, E.; Tellini, R.; Mari, A.; Pillozzi, S.; Fiore, A.; Venturini, S.; Scelzi, S.; Lapini, A.; Minervini, A.; Carini, M.; Nesi, G.; Arcangeli, A.
Data describing the effects of the Macrolide Antibiotic Clarithromycin on preclinical mouse models of Colorectal Cancer
2019 Petroni G.; Stefanini M.; Pillozzi S.; Crociani O.; Becchetti A.; Arcangeli A.
ROS1 rearrangements are uncommon in biliary tract cancers
2020 Mazzoni, Francesca; Petreni, Paolo; Vasile, Enrico; Panebianco, Michele; Casadei-Gardini, Andrea; Negri, Francesca; Lunghi, Alice; Pillozzi, Serena; Vivaldi, Caterina; Gervasi, Erika; Frassineti, Giovanni Luca; Messerini, Luca; Jocollé, Genny; Bisagni, Alessandra; Antonuzzo, Lorenzo; Rossi, Giulio
Somatostatin analogs in pregnant patients with neuroendocrine tumor
2020 Meoni, Giulia; Giommoni, Elisa; Petreni, Paolo; Pillozzi, Serena; Mazzoni, Francesca; Pellegrini, Elisa; Brugia, Marco; Lunghi, Alice; Muto, Andrea; Antonuzzo, Lorenzo
Mutational profile in circulating tumor DNA in a patient affected by low-risk endometrial cancer: Predictable tool of relapse?
2020 Malentacchia F.; Turrini I.; Zepponi F.; Fantappie G.; Sorbi F.; Antonuzzo L.; Fambrini M.; Noci I.; Pillozzi S.
Immune checkpoint inhibitors in the treatment of renal cancer: Current state and future perspective
2020 Lavacchi D.; Pellegrini E.; Palmieri V.E.; Doni L.; Mela M.M.; Di Maida F.; Amedei A.; Pillozzi S.; Carini M.; Antonuzzo L.
Detection of PIK3CA E545A mutation in circulating tumor DNA of a patient affected by uterine carcinosarcoma
2020 Fantappie G.; Malentacchi F.; Turrini I.; Sorbi F.; Castiglione F.; Vergoni F.; Ammatuna C.; Antonuzzo L.; Fambrini M.; Noci I.; Pillozzi S.
Identification of a Gene Panel for Endometrioid Endometrial Cancer: a Possible Prognostic Value?
2020 Malentacchi F, Turrini I, Sorbi F, Projetto E, Castiglione F, Vergoni F, Amunni G, Fambrini M, Petraglia F, Noci I, Pillozzi S
The anti-IgE monoclonal antibody omalizumab as adjuvant treatment in desensitization to carboplatin in patients with ovarian cancer
2021 Vultaggio, Alessandra; Petrella, Maria Cristina; Tomao, Federica; Nencini, Francesca; Mecheri, Valentina; Marini, Andrea; Perlato, Margherita; Vivarelli, Emanuele; De Angelis, Claudia; Ferrarini, Ilaria; Pillozzi, Serena; Matucci, Andrea; Antonuzzo, Lorenzo
Soft tissue sarcoma: An insight on biomarkers at molecular, metabolic and cellular level
2021 Pillozzi S.; Bernini A.; Palchetti I.; Crociani O.; Antonuzzo L.; Campanacci D.; Scoccianti G.
Transgenic mice overexpressing the LH receptor in the female reproductive system spontaneously develop endometrial tumour masses
2021 Lottini, Tiziano; Iorio, Jessica; Lastraioli, Elena; Carraresi, Laura; Duranti, Claudia; Sala, Cesare; Armenio, Miriam; Noci, Ivo; Pillozzi, Serena; Arcangeli, Annarosa
Aflibercept plus folfiri as second-line treatment for metastatic colorectal cancer: A single-institution real-life experience
2021 Lavacchi D.; Roviello G.; Giommoni E.; Dreoni L.; Derio S.; Brugia M.; Amedei A.; Pillozzi S.; Antonuzzo L.
Activity and Safety of NAB-FOLFIRI and NAB-FOLFOX as First-Line Treatment for metastatic Pancreatic Cancer (NabucCO Study)
2021 Giommoni, Elisa; Maiello, Evaristo; Vaccaro, Vanja; Rondini, Ermanno; Vivaldi, Caterina; Tortora, Giampaolo; Toppo, Laura; Giordano, Guido; Latiano, Tiziana Pia; Lamperini, Cinzia; Pillozzi, Serena; Boni, Luca; Antonuzzo, Lorenzo; Di Costanzo, Francesco
Results of the observational prospective RealFLOT study
2021 Giommoni, Elisa; Lavacchi, Daniele; Tirino, Giuseppe; Fornaro, Lorenzo; Iachetta, Francesco; Pozzo, Carmelo; Satolli, Maria Antonietta; Spallanzani, Andrea; Puzzoni, Marco; Stragliotto, Silvia; Sisani, Michele; Formica, Vincenzo; Giovanardi, Filippo; Strippoli, Antonia; Prisciandaro, Michele; Di Donato, Samantha; Pompella, Luca; Pecora, Irene; Romagnani, Alessandra; Fancelli, Sara; Brugia, Marco; Pillozzi, Serena; De Vita, Ferdinando; Antonuzzo, Lorenzo
Association of systemic steroid treatment and outcome in patients treated with immune checkpoint inhibitors: A real-world analysis
2021 Paderi A.; Gambale E.; Botteri C.; Giorgione R.; Lavacchi D.; Brugia M.; Mazzoni F.; Giommoni E.; Bormioli S.; Amedei A.; Pillozzi S.; Cerinic M.M.; Antonuzzo L.
Chasing the target: New phenomena of resistance to novel selective ret inhibitors in lung cancer. updated evidence and future perspectives
2021 Fancelli S.; Caliman E.; Mazzoni F.; Brugia M.; Castiglione F.; Voltolini L.; Pillozzi S.; Antonuzzo L.
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
The ion channels and transporters gene expression profile indicates a shift in excitability and metabolisms during malignant progression of Follicular Lymphoma | 2019 | Magi A.; Masselli M.; Sala C.; Guerriero A.; Laise P.; Puccini B.; Rigacci L.; Breschi C.; Crociani O.; Pillozzi S.; Arcangeli A.; Serena Pillozzi | |
hERG1 and CA IX expression are associated with disease recurrence in surgically resected clear cell renal carcinoma | 2019 | Lastraioli E.; Pillozzi S.; Mari A.; Tellini R.; Duranti C.; Baldazzi V.; Venturini S.; Minervini A.; Lapini A.; Nesi G.; Carini M.; Arcangeli A. | |
Peptides and small molecules blocking the CXCR4/CXCL12 axis overcome bone marrow-induced chemoresistance in acute leukemias | 2019 | Pillozzi S.; Bernini A.; Spiga O.; Lelli B.; Petroni G.; Bracci L.; Niccolai N.; Arcangeli A. | |
Structural and solution chemistry, antiproliferative effects, and serum albumin binding of three pseudohalide derivatives of auranofin | 2019 | Damiano Cirri, Maria Giulia Fabbrini, Lara Massai, Serena Pillozzi, Annalisa Guerri, Alessio Menconi, Luigi Messori, Tiziano Marzo, Alessandro Pratesi | |
hERG1 potassium channel expression predicts survival in clear-cell renal cell carcinoma: A pilot study with a long-term follow up | 2019 | Lastraioli, E.; Tellini, R.; Mari, A.; Pillozzi, S.; Fiore, A.; Venturini, S.; Scelzi, S.; Lapini, A.; Minervini, A.; Carini, M.; Nesi, G.; Arcangeli, A. | |
Data describing the effects of the Macrolide Antibiotic Clarithromycin on preclinical mouse models of Colorectal Cancer | 2019 | Petroni G.; Stefanini M.; Pillozzi S.; Crociani O.; Becchetti A.; Arcangeli A. | |
ROS1 rearrangements are uncommon in biliary tract cancers | 2020 | Mazzoni, Francesca; Petreni, Paolo; Vasile, Enrico; Panebianco, Michele; Casadei-Gardini, Andrea; Negri, Francesca; Lunghi, Alice; Pillozzi, Serena; Vivaldi, Caterina; Gervasi, Erika; Frassineti, Giovanni Luca; Messerini, Luca; Jocollé, Genny; Bisagni, Alessandra; Antonuzzo, Lorenzo; Rossi, Giulio | |
Somatostatin analogs in pregnant patients with neuroendocrine tumor | 2020 | Meoni, Giulia; Giommoni, Elisa; Petreni, Paolo; Pillozzi, Serena; Mazzoni, Francesca; Pellegrini, Elisa; Brugia, Marco; Lunghi, Alice; Muto, Andrea; Antonuzzo, Lorenzo | |
Mutational profile in circulating tumor DNA in a patient affected by low-risk endometrial cancer: Predictable tool of relapse? | 2020 | Malentacchia F.; Turrini I.; Zepponi F.; Fantappie G.; Sorbi F.; Antonuzzo L.; Fambrini M.; Noci I.; Pillozzi S. | |
Immune checkpoint inhibitors in the treatment of renal cancer: Current state and future perspective | 2020 | Lavacchi D.; Pellegrini E.; Palmieri V.E.; Doni L.; Mela M.M.; Di Maida F.; Amedei A.; Pillozzi S.; Carini M.; Antonuzzo L. | |
Detection of PIK3CA E545A mutation in circulating tumor DNA of a patient affected by uterine carcinosarcoma | 2020 | Fantappie G.; Malentacchi F.; Turrini I.; Sorbi F.; Castiglione F.; Vergoni F.; Ammatuna C.; Antonuzzo L.; Fambrini M.; Noci I.; Pillozzi S. | |
Identification of a Gene Panel for Endometrioid Endometrial Cancer: a Possible Prognostic Value? | 2020 | Malentacchi F, Turrini I, Sorbi F, Projetto E, Castiglione F, Vergoni F, Amunni G, Fambrini M, Petraglia F, Noci I, Pillozzi S | |
The anti-IgE monoclonal antibody omalizumab as adjuvant treatment in desensitization to carboplatin in patients with ovarian cancer | 2021 | Vultaggio, Alessandra; Petrella, Maria Cristina; Tomao, Federica; Nencini, Francesca; Mecheri, Valentina; Marini, Andrea; Perlato, Margherita; Vivarelli, Emanuele; De Angelis, Claudia; Ferrarini, Ilaria; Pillozzi, Serena; Matucci, Andrea; Antonuzzo, Lorenzo | |
Soft tissue sarcoma: An insight on biomarkers at molecular, metabolic and cellular level | 2021 | Pillozzi S.; Bernini A.; Palchetti I.; Crociani O.; Antonuzzo L.; Campanacci D.; Scoccianti G. | |
Transgenic mice overexpressing the LH receptor in the female reproductive system spontaneously develop endometrial tumour masses | 2021 | Lottini, Tiziano; Iorio, Jessica; Lastraioli, Elena; Carraresi, Laura; Duranti, Claudia; Sala, Cesare; Armenio, Miriam; Noci, Ivo; Pillozzi, Serena; Arcangeli, Annarosa | |
Aflibercept plus folfiri as second-line treatment for metastatic colorectal cancer: A single-institution real-life experience | 2021 | Lavacchi D.; Roviello G.; Giommoni E.; Dreoni L.; Derio S.; Brugia M.; Amedei A.; Pillozzi S.; Antonuzzo L. | |
Activity and Safety of NAB-FOLFIRI and NAB-FOLFOX as First-Line Treatment for metastatic Pancreatic Cancer (NabucCO Study) | 2021 | Giommoni, Elisa; Maiello, Evaristo; Vaccaro, Vanja; Rondini, Ermanno; Vivaldi, Caterina; Tortora, Giampaolo; Toppo, Laura; Giordano, Guido; Latiano, Tiziana Pia; Lamperini, Cinzia; Pillozzi, Serena; Boni, Luca; Antonuzzo, Lorenzo; Di Costanzo, Francesco | |
Results of the observational prospective RealFLOT study | 2021 | Giommoni, Elisa; Lavacchi, Daniele; Tirino, Giuseppe; Fornaro, Lorenzo; Iachetta, Francesco; Pozzo, Carmelo; Satolli, Maria Antonietta; Spallanzani, Andrea; Puzzoni, Marco; Stragliotto, Silvia; Sisani, Michele; Formica, Vincenzo; Giovanardi, Filippo; Strippoli, Antonia; Prisciandaro, Michele; Di Donato, Samantha; Pompella, Luca; Pecora, Irene; Romagnani, Alessandra; Fancelli, Sara; Brugia, Marco; Pillozzi, Serena; De Vita, Ferdinando; Antonuzzo, Lorenzo | |
Association of systemic steroid treatment and outcome in patients treated with immune checkpoint inhibitors: A real-world analysis | 2021 | Paderi A.; Gambale E.; Botteri C.; Giorgione R.; Lavacchi D.; Brugia M.; Mazzoni F.; Giommoni E.; Bormioli S.; Amedei A.; Pillozzi S.; Cerinic M.M.; Antonuzzo L. | |
Chasing the target: New phenomena of resistance to novel selective ret inhibitors in lung cancer. updated evidence and future perspectives | 2021 | Fancelli S.; Caliman E.; Mazzoni F.; Brugia M.; Castiglione F.; Voltolini L.; Pillozzi S.; Antonuzzo L. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile